Trials / Completed
CompletedNCT00174395
A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine
A Multi-Center, Open-Label, Randomized, Parallel-Group Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine in Early Intervention.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 220 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of early intervention (dosing within 2 hours of onset of the migraine attack) with eletriptan 40mg on mild versus moderate to severe pain intensity of migraine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | eletriptan |
Timeline
- Start date
- 2005-03-01
- Completion
- 2006-10-01
- First posted
- 2005-09-15
- Last updated
- 2021-01-27
Locations
33 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00174395. Inclusion in this directory is not an endorsement.